Download FREE Report Sample
Download Free sampleCefuroxime sodium injection is used for various infections caused by sensitive bacteria, especially respiratory tract infections. COVID-19 has erupted in the world, and the demand for anti-infective drugs is rising, and these drugs are in short supply.
Cefuroxime Sodium Injection Market contains market size and forecasts of Cefuroxime Sodium Injection in global, including the following market information:
Global Cefuroxime Sodium Injection Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Cefuroxime Sodium Injection Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Cefuroxime Sodium Injection companies in 2021 (%)
The global Cefuroxime Sodium Injection market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
0.25g/vial Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cefuroxime Sodium Injection include Hikma, Sagent, Pfizer, Teligent, SteriMax, Fresenius Kabi, Aglobal Care, Guangzhou Baiyunshan Tianxin Pharmaceutical and Sinopharm Weiqida Pharmaceutical, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cefuroxime Sodium Injection manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cefuroxime Sodium Injection Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefuroxime Sodium Injection Market Segment Percentages, by Type, 2021 (%)
0.25g/vial
0.5g/vial
0.75g/vial
1.5g/vial
Global Cefuroxime Sodium Injection Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefuroxime Sodium Injection Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Cefuroxime Sodium Injection Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Cefuroxime Sodium Injection Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cefuroxime Sodium Injection revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Cefuroxime Sodium Injection revenues share in global market, 2021 (%)
Key companies Cefuroxime Sodium Injection sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Cefuroxime Sodium Injection sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Hikma
Sagent
Pfizer
Teligent
SteriMax
Fresenius Kabi
Aglobal Care
Guangzhou Baiyunshan Tianxin Pharmaceutical
Sinopharm Weiqida Pharmaceutical
Shanghai New Asia Pharmacetical
Harbin Pharmaceutical Group
Youcare Pharmaceutical Group
Weikang Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
